Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director · Co-CEO and General Counsel | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 2,153,678 |
Ending reported balance
After 2026-09-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-24 · Grant · Acquired 177,858 · Balance 2,244,475 F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026 Row 2 · 2026-09-24 · Tax withholding · Disposed 90,797 · Balance 2,153,678 F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026
F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 27, 2024 Filed Nov 29, 2024 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 44,621 | $4.50 | $200,794.50 |
DisclosureSEC source: 0001779128-24-000136 · wk-form4_1732922714.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,083,761 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. Read SEC document |
| November 27, 2024 Filed Nov 29, 2024 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 44,621 | $4.25 | $189,639.25 |
DisclosureSEC source: 0001779128-24-000136 · wk-form4_1732922714.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,128,382 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 23:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 44,621 | $3.40 | $151,537.38 |
DisclosureSEC source: 0001779128-24-000128 · wk-form4_1731539153.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,173,003 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.18 to $3.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 16:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 34,018 | $2.85 | $96,951.30 |
DisclosureSEC source: 0001779128-24-000121 · wk-form4_1726243517.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217,624 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 21:21 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 60,834 | $2.94 | $178,851.96 |
DisclosureSEC source: 0001779128-24-000084 · wk-form4_1718659298.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,251,642 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 10,253 | $0.18 Strike: $0.18 | $1,845.54 |
DisclosureSEC source: 0001779128-24-000074 · wk-form4_1718228520.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,264 Underlying: Class A common stock, $0.0001 par value per share · 10,253 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:42 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 10,253 | $0.18 | $1,845.54 |
DisclosureSEC source: 0001779128-24-000074 · wk-form4_1718228520.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,312,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:26 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 22,836 | $3.28 | $74,851.84 |
DisclosureSEC source: 0001779128-24-000053 · wk-form4_1712348772.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,291,121 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 03, 2024 Filed Apr 17, 2024 21:24 UTC Amendment | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,734 | $3.28 | $38,461.71 |
DisclosureSEC source: 0001779128-24-000057 · wk-form4a_1713389054.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,302,223 F1 · shares: The original Form 4, filed on April 5, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on April 3, 2024 as a total of 22,836 shares sold when in fact only 11,734 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 11,102 shares. F2 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.175 to $3.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F1 · balance_after: The original Form 4, filed on April 5, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on April 3, 2024 as a total of 22,836 shares sold when in fact only 11,734 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 11,102 shares. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 18:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 27,857 | $0.18 Strike: $0.18 | $5,014.26 |
DisclosureSEC source: 0001779128-24-000043 · wk-form4_1710959708.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,517 Underlying: Class A common stock, $0.0001 par value per share · 27,857 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 18:35 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 27,857 | $0.18 | $5,014.26 |
DisclosureSEC source: 0001779128-24-000043 · wk-form4_1710959708.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,313,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 9,068 | $0.18 Strike: $0.18 | $1,632.24 |
DisclosureSEC source: 0001779128-24-000035 · wk-form4_1710538659.xml · derivative · entry 6 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 9,068 shares Expires 2027-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 46,487 | $0.18 Strike: $0.18 | $8,367.66 |
DisclosureSEC source: 0001779128-24-000035 · wk-form4_1710538659.xml · derivative · entry 5 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,374 Underlying: Class A common stock, $0.0001 par value per share · 46,487 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 9,068 | $0.18 | $1,632.24 |
DisclosureSEC source: 0001779128-24-000035 · wk-form4_1710538659.xml · nonDerivative · entry 4 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,286,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 46,487 | $0.18 | $8,367.66 |
DisclosureSEC source: 0001779128-24-000035 · wk-form4_1710538659.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,277,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 25,634 | $2.62 | $67,279.00 |
DisclosureSEC source: 0001779128-24-000035 · wk-form4_1710538659.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,230,545 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 26,191 | $2.76 | $72,415.50 |
DisclosureSEC source: 0001779128-24-000035 · wk-form4_1710538659.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,256,179 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.655 to $2.875, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 22:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 22,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-24-000024 · wk-form4_1710280921.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,282,370 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. All of the RSUs will vest on April 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 30,148 | $0.18 Strike: $0.18 | $5,426.64 |
DisclosureSEC source: 0001779128-24-000003 · wk-form4_1704315711.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,068 Underlying: Class A common stock, $0.0001 par value per share · 30,148 shares Expires 2027-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:02 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 30,148 | $0.18 | $5,426.64 |
DisclosureSEC source: 0001779128-24-000003 · wk-form4_1704315711.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,259,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 15, 2023 23:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 6,537 | $3.22 | $21,039.99 |
DisclosureSEC source: 0001779128-23-000140 · wk-form4_1702684788.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,229,386 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 23:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 15,469 | $3.20 | $49,558.04 |
DisclosureSEC source: 0001779128-23-000140 · wk-form4_1702684788.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,235,923 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 23:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 13,963 | $2.95 | $41,167.11 |
DisclosureSEC source: 0001779128-23-000140 · wk-form4_1702684788.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,251,392 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $3.0750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 06, 2023 Filed Oct 6, 2023 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 13,944 | $2.40 | $33,436.32 |
DisclosureSEC source: 0001779128-23-000109 · wk-form4_1696634743.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,265,355 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.335 to $2.435, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 10,798 | $2.41 | $26,045.86 |
DisclosureSEC source: 0001779128-23-000109 · wk-form4_1696634743.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279,299 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.375 to $2.505, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 12,914 | $2.51 | $32,423.18 |
DisclosureSEC source: 0001779128-23-000109 · wk-form4_1696634743.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,290,097 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.495 to $2.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 19:31 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 13,516 | $0.18 Strike: $0.18 | $2,432.88 |
DisclosureSEC source: 0001779128-23-000093 · wf-form4_169325105508915.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,216 Underlying: Class A common stock, $0.0001 par value per share · 13,516 shares Expires 2027-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 19:31 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 13,516 | $0.18 | $2,432.88 |
DisclosureSEC source: 0001779128-23-000093 · wf-form4_169325105508915.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,303,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2023 Filed Jul 10, 2023 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 35,623 | $3.88 | $138,373.98 |
DisclosureSEC source: 0001779128-23-000065 · wf-form4_168902930594947.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,289,495 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.81 to $3.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 07, 2023 Filed Jul 10, 2023 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 27,576 | $3.82 | $105,389.96 |
DisclosureSEC source: 0001779128-23-000065 · wf-form4_168902930594947.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,325,118 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 22:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 27,881 | $3.75 | $104,584.42 |
DisclosureSEC source: 0001779128-23-000065 · wf-form4_168902930594947.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,352,694 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.605 to $3.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · balance_after: Since the date of the reporting person's last ownership report, she transferred 18,727 shares of the Issuers Class A common stock and stock options to purchase 381,722 shares of the Issuers Class A common stock to her ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by her ex-spouse. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 21:10 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 18,439 | $2.83 | $52,246.91 |
DisclosureSEC source: 0001779128-23-000041 · wf-form4_168124741116550.xml · nonDerivative · entry 3 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,399,302 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.805 to $2.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 21:10 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 9,361 | $2.92 | $27,290.12 |
DisclosureSEC source: 0001779128-23-000041 · wf-form4_168124741116550.xml · nonDerivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,417,741 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| April 05, 2023 Filed Apr 11, 2023 21:10 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 12,151 | $2.98 | $36,185.68 |
DisclosureSEC source: 0001779128-23-000041 · wf-form4_168124741116550.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,427,102 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.825 to $3.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 14:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 13,889 | $0.18 Strike: $0.18 | $2,500.02 |
DisclosureSEC source: 0001779128-23-000031 · wf-form4_167906301704784.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,056 Underlying: Class A common stock, $0.0001 par value per share · 13,889 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 14:23 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 13,889 | $0.18 | $2,500.02 |
DisclosureSEC source: 0001779128-23-000031 · wf-form4_167906301704784.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,439,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 15:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 58,423 | $0.18 Strike: $0.18 | $10,516.14 |
DisclosureSEC source: 0001779128-23-000019 · wf-form4_167768448609221.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,945 Underlying: Class A common stock, $0.0001 par value per share · 58,423 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 15:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 58,423 | $0.18 | $10,516.14 |
DisclosureSEC source: 0001779128-23-000019 · wf-form4_167768448609221.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,425,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2023 Filed Jan 12, 2023 15:30 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 5,139 | $3.47 | $17,852.89 |
DisclosureSEC source: 0001779128-23-000013 · wf-form4_167353743455199.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,366,941 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:29 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 16,693 | $0.18 Strike: $0.18 | $3,004.74 |
DisclosureSEC source: 0001779128-23-000002 · wf-form4_167297217810583.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,788 Underlying: Class A common stock, $0.0001 par value per share · 16,693 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:29 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 16,693 | $0.18 | $3,004.74 |
DisclosureSEC source: 0001779128-23-000002 · wf-form4_167297217810583.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,372,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2022 Filed Nov 14, 2022 15:04 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 931,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-22-000121 · wf-form4_166843823239486.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,387 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest on the first day of every calendar quarter following January 1, 2023 (with the first tranche to vest on April 1, 2023), with any remaining unvested RSUs to vest on January 1, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 14:16 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 4,366 | $3.97 | $17,335.20 |
DisclosureSEC source: 0001779128-22-000102 · wf-form4_166549779518155.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,596 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $$3.9700 to $3.9946, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| July 15, 2022 Filed Aug 8, 2022 14:27 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 4,288 | $4.41 | $18,910.08 |
DisclosureSEC source: 0001779128-22-000074 · wf-form4_165996882255160.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,962 Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:39 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-22-000063 · wf-form4_165549833683472.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,061 Underlying: Class A common stock, $0.0001 par value per share · 5,555 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:39 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 5,555 | $0.18 | $999.90 |
DisclosureSEC source: 0001779128-22-000063 · wf-form4_165549833683472.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 20:17 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 6,110 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-22-000058 · primary_doc.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,616 Underlying: Class A common stock, par value $0.0001 per share · 6,110 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 20:17 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 6,110 | $0.18 | $1,099.80 |
DisclosureSEC source: 0001779128-22-000058 · primary_doc.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 14:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, par value $0.0001 per share | 4,387 | $8.60 | $37,728.20 |
DisclosureSEC source: 0001779128-22-000029 · wf-form4_164925586263824.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,585 Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 19:29 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 5,556 | $0.18 Strike: $0.18 | $1,000.08 |
DisclosureSEC source: 0001779128-22-000009 · wf-form4_164400293123759.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,726 Underlying: Class A common stock, par value $0.0001 per share · 5,556 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.